Familial combined hyperlipidemia: Detection and characterization of the hyperlipidemic profile among children and adolescents;Hiperlipemia familiar combinada: Detección y caracterización del fenotipo hiperlipémico en niños y adolescentes

Medicina Clinica

Volumn 109, Issue 5, 1997, Pages 161-164

  Ribalta, Josep ^a,b   La Ville, Agnes E ^a   Heras, Mercedes ^a   Plana, Núria ^a   Masana, Lluís ^a  

^a UNIVERSITAT ROVIRA I VIRGILI   (Spain)

^b Facultat de Quimica   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN; LIPOPROTEIN;

ADOLESCENT; ARTICLE; BLOOD; CHILD; FAMILIAL HYPERLIPEMIA; FEMALE; HUMAN; HYPERLIPIDEMIA; MALE; PHENOTYPE;

ADOLESCENT; APOLIPOPROTEINS; CHILD; FEMALE; HUMANS; HYPERLIPIDEMIA, FAMILIAL COMBINED; HYPERLIPIDEMIAS; LIPOPROTEINS; MALE; PHENOTYPE;

EID: 0347276320     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Schwartz CJ, Valente AJ, Sprague EA. A modern view of atherogenesis. Am J Cardiol 1993; 71: 9-14.
2. Enos WF, Beyer JC, Holmes RH. Pathogenesis of coronary disease in american soldiers killed in Korea. JAMA 1955; 158: 912-914.
3. McNamara JJ, Molot MA, Stremple JF, Cutting RT. Coronary artery disease in combat casualties in Vietnam. JAMA 1971; 216: 1.185-1.187.
4. Newman WP, Freedman DS, Voors AW, Gard P, Srinivasan SR, Cresanta J et al. Serum lipoproteins and systolic blood pressure are related to atherosclerosis in early life: the Bogalusa Heart Study. N Engl J Med 1986; 314: 134-144.
5. Genest JJ Jr, Martin Munley SS, McNamara JR, Ordovas JM, Jenner J, Myers RH et al. Familial lipoprotein disorders in patients with premature coronary artery disease. Circulation 1992; 85: 2.025-2.033.
6. Grundy SM, Chait A, Brunzell JD. Familial combined hyperlipidemia workshop. Arteriosclerosis 1987; 7: 203-207.
7. Castro Cabezas M, De Bruin TWA, Erkelens DW. Familial combined hyperlipidemia: 1973-1991. Neth J Med 1992; 40: 83-95.
8. Kwiterovich PO Jr. Genetics and molecular biology of familial combined hyperlipidemia. Curr Opin Lipid Res 1993; 4: 133-143.
9. Nikkilä EA, Aro A. Family study of serum lipids and lipoproteins in coronary heart disease. Lancet 1973; 1: 954-959.
10. Janus ED, Nicoll AM, Turner PR, Magill P, Lewis B. Kinetic bases of the primary hyperlipidemias: studies of apolipoprotein B turnover in genetically defined subjects. Eur J Clin Invest 1980; 10; 161-172.
11. Cortner JA, Coates PM, Bennett MJ, Cryer DR, Le NA. Familial combined hyperlipidemia: use of stable isotopes to demonstrate overproduction of very-low-density lipoprotein apolipoprotein B by the liver. J Inherited Dis 1991; 14: 915-922.
12. Austin MA, Brunzell JD, Fitch WL, Krauss RM. Inheritance of low density lipoprotein subclass patterns in familial combined hyperlipidemia. Arteriosclerosis 1990; 10: 520-530.
13. Austin MA, Horowitz H, Wijsman E, Krauss RM, Brunzeil J. Bimodality of plasma apolipoprotein B levels in familial combined hyperlipidemia. Atherosclerosis 1992; 92: 67-77.
14. Babirak SP, Iverius P-H, Fujimoto WY, Brunzell JD. Detection and characterization of the heterozygote state for lipoprotein lipase deficiency. Arteriosclerosis 1989; 9: 326-334.
15. Babirak SP, Brown BG, Brunzell JD. Familial combined hyperlipidemia and abnormal lipoprotein lipase. Arterioscler Thromb 1992; 12: 1.176-1.183.
16. Cortner JA, Coates PM, Gallagher PR. Prevalence and expression of familial combined hyperlipidemia in childhood. J Pediatr 1990; 116: 514-519.
17. Jansen S, Zambrana JL, López Miranda J, Blanco A, Blanco J, Jiménez Perepérez JA et al. Posible relación entre sobrepeso y prevalencia de hiperlipemia en hijos de enfermos con hipercolesterolemia familiar heterozigota e hiperlipemia familiar combinada. Med Clin (Barc) 1995; 105: 85-88.
18. Plaza y Grupo de expertes de las Sociedades Espafiolas de Arteriosclerosis, Cardiología, Pediatría, Nutrición y Medicina Preventiva. Informe sobre el colesterol en niños y adolescentes españoles. Clin Invest Arteriosclerosis 1991; 3: 47-66.
19. Vallvé JC, Margalef J, Ribalta J, Turner PR, Masana Ll. Comparación de la determinatión de genotipos y fenotipos de las isoformas de apo E. Clin Invest Arteriosclerosis 1996; 8: 59-65.
20. Schumaker VR, Puppione DL. Sequential flotation ultracentrifugation. Method Enzymol 1986; 128: 155-170.
21. Goldstein JL, Schrott HG, Hazzard WR, Bierman EL, Motulsky AG. Hyperlipidemia in coronary heart disease II: genetic analyses of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidaemia. J Clin Invest 1973; 52: 1.544-1.568.
22. De Silva HV, Lauer SJ, Wang J, Simonet WS, Weisgraber KH, Mahley RW et al. Overexpression of human apolipoprotein C-III in transgenic mice results in accumulation of apolipoprotein B-48 remnants that is corrected by excess apolipoprotein E. J Biol Chem 1994; 269: 2.324-2.335.
23. Aalto-Setälä K, Fisher EA, Chen X, Chajec-Shaul T, Hayek T, Zechner R et al. Mechanism of hypertriglyceridemia in human apolipoprotein (apo) C-III transgenic mice. J Clin Invest 1992; 90; 1.889-1.900.
24. Castro Cabezas M, De Bruin TWA, Jansen H, Kock AW, Kortlandt W, Erkelens DW. Impaired chylomicron remnant clearance in familial combined hyperlipidemia. Arterioscler Thromb 1993; 13: 804-814.
25. Ginsberg HN, Le NA. Goldberg IJ, Gibson JC, Rubinstein A, Warg-lverson P et al. Apolipoprotein B metabolism in subjects with deficiency of apolipoprotein C-III and A-I: evidence that apolipoprotein C-III inhibits catabolism of triglyceride rich lipoproteins by lipoprotein lipase in vivo. J Clin Invest 1986; 8: 1.287-1.295.
26. Auwerx J, Leroy P, Schoonjans K. Lipoprotein lipase: recent contributions from molecular biology. Crit Rev Cl Lab Sci 1992; 29: 243-268.
27. Nordestgaard BG, Lewis B. Intermediate density lipoprotein levels are strong predictors of the extend of aortic atherosclerosis in the St. Thomas's Hospital rabbit strain. Atherosclerosis 1991; 87: 39-46.